Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease

Movement Disorders

Volumn 25, Issue SUPPL. 1, 2010, Pages

  Pfeiffer, Ronald F ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Defecatory dysfunction; Detrusor overactivity; Dysphagia; Gastroparesis

Indexed keywords

CISAPRIDE; DARIFENACIN; DOMPERIDONE; DOXAZOSIN; DUTASTERIDE; FINASTERIDE; LACTULOSE; LUBIPROSTONE; MACROGOL 3350; OXYBUTYNIN; PROKINETIC AGENT; SILDENAFIL; SOLIFENACIN; SORBITOL; TADALAFIL; TAMSULOSIN; TEGASERIDE; TERAZOSIN; TOLTERODINE; TROSPIUM CHLORIDE; UNCLASSIFIED DRUG; VARDENAFIL;

ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOTOXICITY; DEFECATION; DEFECATION DISORDER; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPHAGIA; ERECTILE DYSFUNCTION; HUMAN; NAUSEA; OVERACTIVE BLADDER; PARKINSON DISEASE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SALIVATION; SEXUAL DYSFUNCTION; STOMACH PARESIS; UNSPECIFIED SIDE EFFECT; URINARY DYSFUNCTION; WEIGHT REDUCTION; GASTROINTESTINAL DISEASE; PSYCHOSEXUAL DISORDER; URINARY TRACT DISEASE;

GASTROINTESTINAL DISEASES; HUMANS; PARKINSON DISEASE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; UROLOGIC DISEASES;

EID: 77953408952     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22715     Document Type: Article

References (18)

1. Braak H, de Vos RAI, Bohl J, Del Tredici K. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006; 396: 67-72.
2. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ. Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 1987; 37: 1253-1255.
3. Singaram C, Ashraf W, Gaumnitz EA, et al. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 1995; 346: 861-864.
4. Edwards LL, Pfeiffer RF, Quigley EM, Hofman R, Balluff M. Gastrointestinal symptoms in Parkinson's disease. Mov Disord 1991; 6: 151-156.
5. Abbott RA, Cox M, Markus H, Tomkins A. Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 1992; 46: 879-884.
6. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. In: Ebadi M, Pfeiffer RF, editors. Parkinson's disease. Boca Raton: CRC Press; 2005. p 259-273.
7. Hardoff R, Sula M, Tamir A, et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 2001; 16: 1041-1047.
8. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001; 57: 456-462.
9. Jost WH, Schimrigk K. Constipation in Parkinson's disease. Klin Wochenschr 1991; 69: 906-909.
10. Edwards LL, Quigley EMM, Harned RK, Hofman R, Pfeiffer RF. Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol 1994; 89: 15-25.
11. Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF. Defecatory function in Parkinson's disease: response to apomorphine. Ann Neurol 1993; 33: 490-493.
12. Albanese A, Brisinda G, Bentivoglio AR, Maria G. Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. Am J Gastroenterol 2003; 98: 1439-1440.
13. Winge K, Fowler CJ. Bladder dysfunction in parkinsonism: mechanisms, prevalence, symptoms, and management. Mov Disord 2006; 21: 737-745.
14. Singer C. Urological dysfunction. In: Pfeiffer RF, Bodis-Wollner I, editors. Parkinson's disease and nonmotor dysfunction. Totowa, NJ: Humana Press; 2005. p 139-148.
15. Galloway NT. Urethral sphincter abnormalities in parkinsonism. Br J Urol 1983; 55: 691-693.
16. Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001; 92: 76-85.
17. Waters C, Smolowitz J. Impaired sexual function. In: Pfeiffer RF, Bodis-Wollner I, editors. Parkinson's disease and nonmotor dysfunction. Totowa, NJ: Humana Press; 2005. p 127-137.
18. Okun MS, McDonald WM, DeLong MR. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. Arch Neurol 2002; 59: 807-811.